JBIO vs ABOS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

JBIO

30.2
AI Score
VS
ABOS Wins

ABOS

52.3
AI Score

Investment Advisor Scores

JBIO

30score
Recommendation
SELL

ABOS

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO ABOS Winner
Net Income -96.13M -78.82M ABOS
Operating Income -102.36M -79.52M ABOS
ROE -21.9% -227.7% JBIO
ROA -20.4% -92.1% JBIO
Total Assets 472.11M 85.56M JBIO
Cash 107.25M 53.08M JBIO
Current Ratio 14.93 1.89 JBIO

Relative Price Performance (Last 90 Days)

JBIO 1M: +17.3% · 3M: -31.2% ABOS 1M: -87.2% · 3M: -92.0%

Current Technical Phase

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

ABOS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -27.8%), weak momentum, RSI 22

RSI (14): 21.6 · Price: $0.21

Fundamentals Snapshot

Metric JBIO ABOS
Market Cap — —
Forward P/E -6.1 -0.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — -261.2%
Operating Margin 0.0% 0.0%
EPS -1.92 -1.55
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABOS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.